Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1

Status

Terminated 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 1Multiple Pulmonary Nodules 1Lung Neoplasms 1Liver Neoplasms 1Hemorrhage 1Blood Loss, Surgical 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Interventional × Neuromuscular Blockade × Clear all
NCT07395375 2026-02-09

NIVA-TSLR

The First Affiliated Hospital of Guangzhou Medical University

Phase NA Not yet recruiting
1,600 enrolled
Thoracic

Lung Neoplasms, Multiple Pulmonary Nodules

NCT04609410 2025-08-07

MODELS

Università Vita-Salute San Raffaele

Phase NA Terminated
48 enrolled
Gastrointestinal

Hemorrhage, Liver Neoplasms, Blood Loss, Surgical

NCT03063255 2021-03-24

Comparison of Obturator Nerve Blockade and Neuromuscular Blockade

University of Florida

Phase 4 Completed
60 enrolled 8 charts
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡